MBX Biosciences (MBX) has priced its public offering of 11,108,055 shares at $18.00 per share. The upsized offering is expected to generate gross proceeds of approximately $199.9 million for the ...

The US stock market slipped Wednesday, just a day after it had closed higher for 3 straight sessions. Overall, the market shows mixed signals - optimism in some sectors, caution in others.

TJX Companies is a buy with a targeted 10% return, strong fundamentals, and growth driven by younger shoppers. Read here for more on TJX stock.

CVS Health may be deeply undervalued despite recent pressures. Q2/25 results showed strong revenue growth. See more on CVS stock here.

See if DoubleLine Income Solutions Fund (DSL) fits your income strategy. Learn about its yield, risks, and how it compares to other CEFs.

Alphamin Resources has high-grade tin, resilient operations, and a projected 20% dividend yield in 2026. Read more on AFM:CA ...

Rambus continues to deliver robust growth, driven by strong DDR5 memory interface chip sales and industry-leading market ...

Federal Signal ( NYSE: FSS) said on Wednesday that it has signed a definitive agreement to acquire Scranton Manufacturing Company d/b/a New Way Trucks, a U.S.-based designer and manufacturer of refuse ...

Edge Autonomy acquisition diversifies Redwire's business into strong defense demand for autonomous drones amid rising ...

Stocks slid for the second straight day, oil kept climbing, gold sulked, and the Fed wheezed into its microphone about ...

Kovo+ Holdings ( TSXV: KOVO:CA) announced on Wednesday the resignation of Justin Anderson, Chief Executive Officer, due to health reasons, effective immediately. Michael Steele, a current director of ...

Moderna opens UK-based MITC to produce mRNA vaccines for NHS and advance research in cancer and rare diseases.